"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to PMVP. [ FAQ on what and how to ask] For non-PMVP questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. David H. Mack Ph.D.
Headquarter: 400 Alexander Park Drive, Suite 301, Princeton, NJ, United States, 08540
Industry: Biotechnology, Employees: 47
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
My Watchlist
